Aurora Cannabis (ACB) EBIAT (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of EBIAT data on file, last reported at -$1.4 million in Q4 2025.

• EBIAT for Q4 2025 came in at -$1.4 million, down 106.75% year-over-year; the trailing twelve-month figure through Dec 2025 was -$56.3 million (down 705.25% YoY), and the FY2025 annual result was $11.0 million, up 121.35% from the prior year.
• EBIAT rose to -$1.4 million in Q4 2025 per ACB's latest filing, from -$38.5 million in the prior quarter.
• Over five years, EBIAT peaked at $20.2 million in Q4 2024 and troughed at -$799.1 million in Q1 2022.
• A 5-year average of -$100.5 million and a median of -$27.6 million in 2022 frame the typical range for EBIAT.
• On a YoY basis, EBIAT climbed as much as 261.26% in 2024 and fell as far as 3056.05% in 2024.
• A 5-year view of EBIAT shows it stood at -$59.6 million in 2021, then rose by 16.98% to -$49.5 million in 2022, then soared by 74.68% to -$12.5 million in 2023, then jumped by 261.26% to $20.2 million in 2024, then plunged by 106.75% to -$1.4 million in 2025.
• Business Quant data shows ACB's EBIAT at -$1.4 million in Q4 2025, -$38.5 million in Q3 2025, and -$14.3 million in Q2 2025.